CAS 1612191-86-2

Formel: C25H44O3

InChl: InChI=1S/C25H44O3/c1-5-17-21-14-16(27)8-11-25(21,4)20-9-12-24(3)18(15(2)10-13-26)6-7-19(24)22(20)23(17)28/h15-23,26-28H,5-14H2,1-4H3/t15-,16-,17-,18-,19+,20+,21+,22+,23-,24-,25-/m1/s1

InChI Key: HYCMOIGNYNCMRH-APIYUPOTSA-N

SMILES: CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCO)C)C)O

BAR502

CAS: 1612191-86-2

BAR502

Formel: C₂₅H₄₄O₃

Reinheit: ≥98%

Molekulargewicht: 392.62

Ref: 54-BUP04705

24-Norcholane-3,7,23-triol, 6-ethyl-, (3α,5β,6α,7α)-

CAS: 1612191-86-2

Formel: C₂₅H₄₄O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 392.6151

Ref: IN-DA00AR2H

BAR502

CAS: 1612191-86-2

BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM).

Formel: C₂₅H₄₄O₃

Reinheit: 99.95%

Farbe und Form: Solid

Molekulargewicht: 392.6151

Ref: TM-TQ0252

BAR502

CAS: 1612191-86-2

Formel: C₂₅H₄₄O₃

Molekulargewicht: 392.62

Ref: 4Z-C-57111

BAR502

CAS: 1612191-86-2

Formel: C₂₅H₄₄O₃

Molekulargewicht: 392.6

Ref: BE-RMCC229015

BAR 502-d5

Kontrolliertes Produkt

CAS: 1612191-86-2

Formel: C₂₅H₃₉D₅O₃

Farbe und Form: Neat

Molekulargewicht: 397.646

Ref: TR-B161226

BAR502

Kontrolliertes Produkt

CAS: 1612191-86-2

BAR502 is a drug that is used in clinical trials as a treatment for chronic liver disease. BAR502 activates the nuclear receptor PPARγ, which has been shown to improve insulin sensitivity in animals with chronic liver disease. The mechanism of action of BAR502 has not been fully elucidated, but it may be due to its ability to decrease lipid accumulation and improve glucose tolerance in adipose tissue. BAR502 binds to PPARγ receptors and alters the expression of genes involved in energy metabolism, such as fatty acid synthase and gluconeogenic enzymes. The clinical relevance of BAR502 has not yet been determined.

Formel: C₂₅H₄₄O₃

Reinheit: Min. 95%

Molekulargewicht: 392.62 g/mol

Ref: 3D-MPC19186